Genitourinary Syndrome Clinical Trials

1 recruiting

Genitourinary Syndrome Trials at a Glance

16 actively recruiting trials for genitourinary syndrome are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 13 trials, with the heaviest enrollment activity in Madrid, Brussels, and Cagliari. Lead sponsors running genitourinary syndrome studies include Centro de Atenção ao Assoalho Pélvico, Fondazione IRCCS Policlinico San Matteo di Pavia, and Centre Hospitalier Universitaire Saint Pierre.

Browse genitourinary syndrome trials by phase

Treatments under study

About Genitourinary Syndrome Clinical Trials

Looking for clinical trials for Genitourinary Syndrome? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Genitourinary Syndrome trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Genitourinary Syndrome clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Not Applicable

Er:YAG Laser Combined With Vaginal Estriol for Genitourinary Syndrome of Menopause

Genitourinary Syndrome of Menopause
University of Nove de Julho60 enrolled1 locationNCT06873971
Recruiting
Not Applicable

Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs.

Sexual FunctionQuality of LifeGenitourinary Syndrome of Menopause+5 more
Mucosa Innovations, S.L.80 enrolled1 locationNCT06962345
Recruiting
Not Applicable

Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause

Genitourinary Syndrome of Menopause
Stratpharma AG100 enrolled3 locationsNCT05672901
Recruiting
Not Applicable

Vaginal Changes After CO2 Laser

Genitourinary Syndrome of Menopause
University of California, Irvine50 enrolled1 locationNCT06691178
Recruiting
Not Applicable

Radiofrequency and Exercise-based Rehabilitation on Symptoms Associated With Pelvic Floor Dysfunctions in Breast Cancer

Breast CancerPhysical ExerciseGenitourinary Syndrome+1 more
SERGIO MONTERO NAVARRO117 enrolled1 locationNCT06694519
Recruiting
Not Applicable

Efficacy of Non-ablative Radiofrequency Combined With Pelvic Floor Muscle Training for Genitourinary Syndrome of Menopause in Breast Cancer Survivors (RF-SGM)

Breast CancerGenitourinary Syndrome of Menopause (GSM)
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal50 enrolled1 locationNCT07034976
Recruiting
Not Applicable

Effectiveness of a Telerehabilitation Program for Improving Sexual Function and Reducing Pain in Menopausal Women

MenopauseGenitourinary Syndrome of MenopauseDyspareunia
Instituto Médico Tecnológico SL90 enrolled1 locationNCT06710002
Recruiting
Not Applicable

Genitourinary Syndrome of Menopause in Breast Cancer

Breast Cancer FemaleGenitourinary Syndrome of Menopause (GSM)
University of Alcala182 enrolled1 locationNCT06721936
Recruiting
Not Applicable

Concomitant Treatment with Topical Hyaluronic Acid and High Concentration Oxygen Therapy (Vaginal Natural Oxygenation Device - VNOD) in the Improvement of Symptoms Related to Genitourinary Syndrome of Menopause in Women with Natural and Oncological Postmenopause: Open-Label, Single-Center, Randomize

Genitourinary Syndrome of Menopause
Fondazione IRCCS Policlinico San Matteo di Pavia80 enrolled1 locationNCT06879938
Recruiting
Not Applicable

Treatment of Vulvo-vaginal Atrophy (VVA) Using Vaginal Dilator in Addition to Usual Treatment

Vulvo Vaginal AtrophyGenitourinary Syndrome of Menopause (GSM)Vaginal Atrophy in Breast Cancer Patients+4 more
Centre Hospitalier Universitaire Saint Pierre160 enrolled1 locationNCT06828640
Recruiting
Not Applicable

Vaginal CO2 Laser Therapy for Genitourinary Syndrome in Breast Cancer Survivors

Genitourinary Syndrome of Menopause
University of Aarhus60 enrolled1 locationNCT06007027
Recruiting

Combination of the Vaginal Laser With a Moisturizing and Repairing Niosomal Gel in the Treatment of Genitourinary Syndrome in Oncology Patients

Genitourinary Syndrome of Menopause
Hospital Universitari de Bellvitge30 enrolled1 locationNCT06508788
Recruiting
Phase 4

Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit

Genitourinary Syndrome of Menopause
Fundación Santiago Dexeus Font192 enrolled1 locationNCT06425978
Recruiting

Non-ablative Diode Laser Therapy for Genitourinary Syndrome of Menopause: A Prospective Study on Efficacy, Safety, and Quality of Life and Sexuality Impact

Genitourinary Syndrome of Menopause
University of Cagliari50 enrolled1 locationNCT06503003
Recruiting
Not Applicable

Use of Fractional CO2 Laser Versus Erbium:YAG Laser for the Treatment of GSM in Patients Using Aromatase Inhibitors

Genitourinary Syndrome of Menopause
Universitaire Ziekenhuizen KU Leuven162 enrolled1 locationNCT05713435
Recruiting
Not Applicable

Radiofrequency Non-ablative in the Treatment of Genitourinary Syndrome of Menopause

Genitourinary Syndrome of Menopause
Centro de Atenção ao Assoalho Pélvico58 enrolled1 locationNCT03506594